
In this episode of Models & Molecules, Do Soon Kim, Head of Product at Xaira Therapeutics, discusses his journey in the biotech and AI sectors, emphasizing the importance of effective communication in fostering collaboration between different scientific disciplines. The conversation explores the potential of machine learning to reshape our understanding of intelligence and moving beyond the limits of human intuition to decode complex biology.Read the full interview: https://enpicom.com/models-molecules/do-soon-kim-navigating-the-convergence-of-tech-and-pharma/
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Melody Shahsavarian | Agentic AI and the Digital Transformation of Pharma R&D

Iddo Weiner | Data, moats, and open science: Building scalable AI applications for bio

Talip Uçar | Inside Boltz's open-source bet on the future of AI-driven drug discovery

Steve Comeau | From novel binder design to the realities of AI in complex therapeutics
Free AI-powered recaps of Models & Molecules and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.